Molecular genetic analysis of von Hippel-Lindau disease

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 527-533

  Richards, F M ^a   Webster, A R ^b   Mcmahon, R ^b   Woodward, E R ^c   Rose, S ^d   Maher, E R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Haemangioblastoma; Phaeochromocytoma; Renal cell carcinoma; VHL tumour suppressor gene; Von Hippel Lindau disease

Indexed keywords

ALLELE; CONFERENCE PAPER; DISEASE PREDISPOSITION; DNA DETERMINATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; HEMANGIOMATOSIS; HUMAN; MOLECULAR GENETICS; MORBIDITY; MORTALITY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

AGE OF ONSET; DIAGNOSIS, DIFFERENTIAL; GENETIC SCREENING; GENOTYPE; GERM-LINE MUTATION; HIPPEL-LINDAU DISEASE; HUMANS; LINKAGE (GENETICS); PHENOTYPE;

EID: 0031862350     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00334.x     Document Type: Conference Paper

References (36)

1. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA. Clinical features and natural history of von Hippel-Lindau disease. Quart J Med 1990; 77: 1151-63.
2. Decker HJH, Weidt EJ, Brieger J. The von Hippel-Lindau tumour suppressor gene. Cancer Genet Cytogenet 1997; 93: 74-83.
3. Maher ER, Iselius L, Yates JRW, Littler M, Benjamin C, Harris R. et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28: 443-7.
4. Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995; 4: 2139-43.
5. Glenn GM, Daniel LN, Choyke P, Linehan WM, Oldfield E, Gorin MB et al. Von Hippel-Lindau disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet 1991; 87: 207-10.
6. Neumann HPH, Weistler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991; 337: 1052-4.
7. Green JS, Bowmer MI, Johnson GJ. Von Hippel-Lindau disease in a Newfoundland kindred. Can Med Assoc J 1986; 134: 133-8.
8. Maher ER, Webster AR, Moore AT. Clinical features and molecular genetics of von Hippel-Lindau disease. Ophthalmic Genet 1995; 16: 79-84.
9. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcott ML et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993; 260: 1317-20.
10. Evans DGR, Maher ER, Macleod R, Davies DR, Craufurd D. Uptake of genetic testing for cancer predisposition. J Med Genet 1997; 34: 746-8.
11. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 332: 268-9.
12. Hosoe S, Brauch H, Latif F, Glenn G, Daniel L, Bale S et al. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 1990; 8: 634-40.
13. Maher ER, Bentley E, Yates JRW, Latif F, Lerman M, Zbar B et al. Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. Genomics 1991; 10: 957-60.
14. Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS. Choyke PL et al. Genetic flanking markers reline diagnostic criteria and provide insights into the genetics of von Hippel-Lindau disease. Proc Natl Acad Sci USA 1991; 88: 2864-8.
15. Richards FM, Maher ER, Latif F, Phipps ME, Tory K, Lush M et al. Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene. J Med Genet 1993; 30: 104-7.
16. Crossey PA, Maher ER, Jones MH, Richards FM, Latif F, Phipps ME et al. Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Mol Genet 1993; 2: 279-82.
17. Richards FM, Phipps ME, Latif F, Yao M, Crossey PA, Foster K et al. Mapping the von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993; 2: 879-82.
18. Yao M, Latif F, Orcutt ML, Kuzmin I, Stackhouse T, Zhou FW et al. Von Hippel-Lindau disease: identification of deletion mutations by pulsed field gel electrophoresis. Hum Genet 1993; 92: 605-14.
19. Payne SJ, Richards FM, Maher ER. A PCR-generated Accl RFLP in the 3′ untranslated region of the von Hippel-Lindau disease (VHL) tumour suppressor gene. Hu Mol Genet 1994; 3: 390.
20. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutation 1995; 5: 66-75.
21. Richards FM, Latif F, Lerman MI, Zbar B, Maher ER. Taq 1 and Pst 1 RFLPs in the von Hippel-Lindau disease gene (VHL). Hu Mol Genet 1993; 2: 1750.
22. Maher ER, Bentley E, Payne SJ, Latif F, Richards FM, Chiano M et al. Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers. J Med Genet 1992; 29: 902-5.
23. Glenn GM, Linehan M, Hosoe S et al. Screening for von Hippel-Lindau disease by DNA-polymorphism analysis. JAMA 1992; 267: 1226-31.
24. Olschwang S, Boisson C, Richard S, Resche F, Thomas G. DNA-based presymptomatic diagnosis for the von Hippel-Lindau disease by linkage analysis. Eur J Hum Genet 1995; 3: 108-15.
25. Maddock IR, Moran A, Maher ER, Teare MD, Norman A. Payne SJ et al. A genetic register for von Hippel-Lindau disease. J Med Genet 1996; 33: 120-27.
26. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM et al. Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America. Europe. and Japan. Human Mutation 1996; 8: 348-57.
27. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 1996; 33: 328-32.
28. Richards FM, Crossey PA, Phipps ME, Foster K, Latif F, Evans G et al. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hu Mol Genet 1994; 3: 595-8.
29. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hu Mol Genet 1994; 3: 1303-8.
30. Clinical Research Group for VHL in Japan. Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Hu Mol Genet 1995; 4: 2233-7.
31. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H et al. Von Hippel-Lindau disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995; 95: 551-6.
32. Chen F, Slife L, Kishida T, Mulvihill J, Tisherman SE, Zbar B. Genotype-phenotype correlation in von Hippel-Lindau disease; identification of a mutation associated with VHL Type 2A. J Med Genet 1996; 33: 716-7.
33. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TWJ, Sampson JR, Ponder BAJ, Maher ER. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet 1995; 32: 885-6.
34. Woodward ER, Eng C, McMahon R, Affara NA, Ponder BAJ, Maher ER. Genetic predisposition to pheochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hu Mol Genet 1997; 6: 1051-6.
35. Neumann HPH, Eng C, Mulligan L, Glavac D, Ponder BAJ, Maher ER et al. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 1995; 274: 1149-51.
36. Lamiell JM, Salazar FG, Hsia YE. Von Hippel-Lindau disease affecting 43 members of a single kindred. Med 1989; 68: 1-29.